Search

8 results in Keywords: FDA drugs

Biological and Medicinal Chemistry

Working Paper

In-Silico FDA-Approved Drug Repurposing to Find the Possible Treatment of Coronavirus Disease-19 (COVID-19)

Kumar Sharp, Dr. Shubhangi Dange

Version 1 posted 21 May 2020

937

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins

Alessandro Contini

Version 1 posted 13 February 2020

8,645

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs

Rimanshee Arya, Amit Das, Vishal Prashar, Mukesh Kumar

Version 2 posted 20 February 2020

8,862

Downloads

Citations

Theoretical and Computational Chemistry

Working Paper

Old Arsenal to Combat New Enemy: Repurposing of Commercially Available FDA Approved Drugs Against Main Protease of SARS-CoV2.

Gagandeep Singh, vishal srivastava, Ritpratik Mishra, Gaurav Goel, Tapan Chaudhuri

Version 1 posted 05 October 2020

552

Downloads

Citations

Theoretical and Computational Chemistry

Working Paper

Drug and Drug-like Molecule Binding to Interface of SARS-CoV-2 Sprotein:human ACE2 Complex: A Density Functional Theory Study

CH Suresh

Version 1 posted 08 October 2020

903

Downloads

Biological and Medicinal Chemistry

Working Paper

Combined Deep Learning and Molecular Docking Simulations Approach Identifies Potentially Effective FDA Approved Drugs for Repurposing Against SARS-CoV-2

Muhammad Umer Anwar, Farjad Adnan, Asma Abro, Muhammad Rayyan Khan, Asad Ur Rehman, Muhammad Osama, Saad Javed, Ahmadullah Baig, Muhammad Raffey Shabbir, Muhammad Zaman Assir

Version 1 posted 04 May 2020

1,831

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

In Silico Molecular Dynamics Docking of Drugs to the Inhibitory Active Site of SARS-CoV-2 Protease and Their Predicted Toxicology and ADME

Leif Peterson

Version 1 posted 23 April 2020

1,182

Downloads

Citations

Biological and Medicinal Chemistry

Working Paper

Drug Repurposing for Coronavirus (COVID-19): In Silico Screening of Known Drugs Against the SARS-CoV-2 Spike Protein Bound to Angiotensin Converting Enzyme 2 (ACE2) (6M0J)

Konstantinos Kalamatianos

Version 5 posted 20 July 2021

2,026

Downloads

Search

Refine Search

8 results in FDA drugs in Keywords: FDA drugs

In-Silico FDA-Approved Drug Repurposing to Find the Possible Treatment of Coronavirus Disease-19 (COVID-19)

Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins

Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs

Old Arsenal to Combat New Enemy: Repurposing of Commercially Available FDA Approved Drugs Against Main Protease of SARS-CoV2.

Drug and Drug-like Molecule Binding to Interface of SARS-CoV-2 Sprotein:human ACE2 Complex: A Density Functional Theory Study

Combined Deep Learning and Molecular Docking Simulations Approach Identifies Potentially Effective FDA Approved Drugs for Repurposing Against SARS-CoV-2

In Silico Molecular Dynamics Docking of Drugs to the Inhibitory Active Site of SARS-CoV-2 Protease and Their Predicted Toxicology and ADME

Drug Repurposing for Coronavirus (COVID-19): In Silico Screening of Known Drugs Against the SARS-CoV-2 Spike Protein Bound to Angiotensin Converting Enzyme 2 (ACE2) (6M0J)

8 results in Keywords: FDA drugs